Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Martin Robinson, Xavier García del Muro et al.|Annals of Oncology|2018Cited by 1.6k
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Jean‐Yves Blay, Martin Robinson et al.|Annals of Oncology|2018Cited by 751
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPancras C.W. Hogendoorn, D. Vanel, Nick Athanasou et al.|Annals of Oncology|2010Cited by 718
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Ofer Merimsky, Stefan Bielack et al.|Annals of Oncology|2018Cited by 641
Epithelial-mesenchymal transition and nuclear β-catenin induced by conditional intestinal disruption of<i>Cdh1</i>with<i>Apc</i>is E-cadherin EC1 domain dependentJulia Matheson, A. Bassim Hassan|Oncotarget|2016Cited by 8